"10.1371_journal.pone.0053923","plos one","2013-01-11T00:00:00Z","Linda Kwakkenbos; Erin Arthurs; Frank H J van den Hoogen; Marie Hudson; Wim G J M van Lankveld; Murray Baron; Cornelia H M van den Ende; Brett D Thombs; for the Canadian Scleroderma Research Group","Department of Rheumatology, Sint Maartenskliniek Nijmegen, The Netherlands; Department of Psychiatry, McGill University, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, Québec, Canada; Department of Medicine (Division of Rheumatology), McGill University, Montréal, Québec, Canada; Department of Educational and Counselling Psychology, McGill University, Montréal, Québec, Canada; School of Nursing, McGill University, Montréal, Québec, Canada; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada","Conceived and designed the experiments: LK EA FH MH WL MB CE BDT. Performed the experiments: LK EA FH MH WL MB CE BDT. Analyzed the data: LK EA BDT. Contributed reagents/materials/analysis tools: FH MH WL MB CE. Wrote the paper: LK EA FH MH WL MB CE BDT.","Actelion Pharmaceuticals and Pfizer Inc. have provided unrestricted educational and research funds to the Canadian Scleroderma Research Group. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","01","Linda Kwakkenbos","LK",9,TRUE,8,8,3,8,TRUE,TRUE,TRUE,1,"9",TRUE
